Boulder-based biotech SomaLogic has entered a five-year partnership with the Food & Drug Administration
By: Colorado BioScience Association Date: 11/11/2020
It can be very difficult to manufacture generic versions of biologic drugs. But SomaLogic has a test that can help determine whether a new drug candidate is similar enough to the original drug to be considered a generic.
Find out more in the Denver Business Journal article.
Categories: Ecosystem News